Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Wheezing After Early-Life Antibiotics: Blame the Underlying Chest Infection More Than the Antibiotics

07.08.2008
Children who are given antibiotics in their first three months often wheeze at 15 months of age. However, this wheezing is probably more due to the presence of chest infections than to the use of antibiotics.

These were the key findings of research carried out by researchers in New Zealand, and published in this month’s edition of Clinical and Experimental Allergy.

This work built on the fact that the prevalence both of asthma and the use of antibiotics have risen since the 1960s. Using antibiotics reduces a person’s exposure to bacterial infections and disturbs healthy populations of bacteria in the body, and the question is whether this then leaves a person more prone to develop asthma.

The researchers recruited a group of 1,000 babies at birth and contacted the parents at 3 months, 15 months and then yearly until they were four years old. Each time, they collected data about chest infections, asthma and their use of antibiotics. The data showed that by the time the children had reached 15 months old, nearly three quarters (72.1%) had been given antibiotics. In addition 11.8% had asthma, 39.6% had eczema and 21.2% had a recurring itchy scaly rash.

The researchers then looked at the data to see whether there was any indication that the antibiotics caused these effects and found that by adjusting for the effects of chest infections the association between antibiotics and wheezing was very much reduced.

"Our results strongly suggest that the reason that some children who have been given antibiotics appear to develop asthma is because they had a chest infection and the symptoms of the chest infection in young children can be confused with the start of asthma,” says Julian Crane, a senior study investigator at the Wellington Asthma Research Group in Wellington, New Zealand. “Antibiotics are given to treat the respiratory condition and rather than being a cause of asthma, as has been previously suggested, they are used for chest infections which can indicate an increased risk of asthma, or be mistaken for it.”

One of the underlying issues is that it is often difficult to distinguish between asthma and chest infections at an early age. Consequently some infants who are given antibiotics to cure a chest infection may really have been suffering from the early symptoms of asthma.

“Our data still leaves open the possibility that antibiotics may affect the development of eczema and itchy skin by four years and allergic hypersensitivity by 15 months,” says Crane.

Jennifer Beal | alfa
Further information:
http://www.wiley.co.uk

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>